A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients
Clinical trial NCT00634348 · COMPLETED
Trial details
- NCT number
- NCT00634348
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.